Brussels, 17 December 2022 – Seven companies specialized in healthcare logistics, including PHSE a leading company in pharmaceutical logistics, have entered into the alliance Skandi Network, the first international GDP-compliant temperature-controlled distribution network dedicated to life science goods....
PHSE, leading company in pharmaceutical logistics, strengthens its presence in the Italian market through the acquisition of Duimex, active in temperature-controlled transport of clinical trials, biological samples and in the management of “special services”...
Phse, italian excellence in temperature-controlled transport of vaccines, pharmaceutical, biological products and clinical trials at a global level, is partner of the commissarial structure in the urgent transport of anti-covid vaccines from the main storage centers to vaccinal hubs throughout the italian territory...
PHSE, leader in temperature-controlled pharmaceutical logistics, strengthens its presence in the asian market through the acquisition of Indian company RAPIDA TIME & TEMPERATURE LLP (“time & temperature”), specialized in the transport of clinical trials and active pharmaceutical ingredients (api)...
Phse enters into agreement to welcome new partner Eddy De vita and NB Aurora holding 70% shares. The founders partner will continue to hold 30% and guarantee business continuity. Phse will continue to be indipendent and invest to be the first operator specialized in...
Via G. Matteotti 35 64028 SILVI MARINA (TE) Aree di Competenza: Abruzzo e Marche...
Phse, leader in temperature-controlled pharmaceutical logistics, acquires Tek Freight, a British company operating in the land transport of drugs and biological samples...
